Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2007
11/28/2007CN101077359A Skin healthy powder
11/28/2007CN101077356A Application for polysaccharide extraction of grateloupia filicina in preparing antitumor medicine and other medicines
11/28/2007CN101077354A Technology for preventing and treating animal nutritional diarrhea
11/28/2007CN101077353A Cardiac and cerebral vascular disease treating medicine
11/28/2007CN101077352A Eye preparation containing lactose-azithromycin
11/28/2007CN101077351A Soft capsules containing roxithromycin
11/28/2007CN101077350A Compostion and method of treating gonad dysfunction
11/28/2007CN101077349A Total alkaloids of subprostrate sophora root soft capsules and preparation method and application thereof
11/28/2007CN101077348A Amoxicillin-clavulantes sustained release tablets
11/28/2007CN101077347A Multifunctional membrane used for glaucoma post-operation and preparation method thereof
11/28/2007CN101077346A Application of N-substituted isatin derivates in preparing anti-tumor medicine
11/28/2007CN101077345A Application of Tagalsin C and its homologous compound in preparing anti-tumor medicine
11/28/2007CN101077344A Infusion preparation of ibuprofen and preparation method thereof
11/28/2007CN101077343A Dexibuprofen granule and preparation method thereof
11/28/2007CN101077342A Method for formulating nutrition replenisher special-purpose used for children amblyopia
11/28/2007CN101077341A Application of aurantio-obtusifolin or its derivates in preparing hypolipidemic drug
11/28/2007CN101077339A Dexibuprofen effervescent tablet and preparation method thereof
11/28/2007CN101077337A Vitamin injection used for promoting female animal estrus and Increasing breeding and preparation method thereof
11/28/2007CN101077336A Injection containing ketoprofen and preparation method thereof
11/28/2007CN101077333A External applied gel with butenafine hydrochloride as principal ingredient
11/28/2007CN100351281C Process of making press molded materials using heat activated tertiary amine urethane catalysts
11/28/2007CN100351264C Antiviral nucleoside derivatives
11/28/2007CN100351263C Pyrazole derivative, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof
11/28/2007CN100351262C Process for producing glycoside
11/28/2007CN100351261C Crystalline glucosamine sulphate metal salts and its preparation method
11/28/2007CN100351260C Polysaccharide vaccine for staphylococcal infections
11/28/2007CN100351259C Sulfur-containing phospholipid derivatives
11/28/2007CN100351258C Crystals of quinolinecarboxylic acid derivative solvate.
11/28/2007CN100351256C Antidepressant piperidine derivatives of heterocycle-fused benzodioxans
11/28/2007CN100351255C Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic
11/28/2007CN100351253C Pyrrolo [2,3-d] pyrimidine compounds as immunosuppressive agents
11/28/2007CN100351252C Novel process for the synthesis of carboxylic acid phenylamide
11/28/2007CN100351251C Indolylmaleimide derivatives
11/28/2007CN100351250C Nobel compounds having selective inhibiting effect at GSK3
11/28/2007CN100351249C Quinolinone derivatives as tyrosine kinase inhibitors
11/28/2007CN100351248C Genistein derivatives and their preparation process and use
11/28/2007CN100351245C Oxa- and thiadiazoles and their use as metalloproteinase inhibitors
11/28/2007CN100351244C Bis-aromatic alkanols
11/28/2007CN100351242C Processes and intermediates for preparing anti-cancer compounds
11/28/2007CN100351241C Stable polymorph of N-(3-ethynylphenylamino)-6,7-bis (2-methoxyethoxy)-4-quinazolinamine hydrochloride, method of production and pharmaceutical uses thereof
11/28/2007CN100351239C Pyrimidine derivatives and their use as CB2 modulators
11/28/2007CN100351238C New derivatives of erythromycin, their preparation process and their use as medicaments
11/28/2007CN100351237C Novel hererocyclic compound and preparation thereof and medicine composition containing same and use thereof in medicine
11/28/2007CN100351236C 1-heterocyclylalkyl-3-sulfonyl-indole or -indazole derivatives as 5-hydroxytryptamine-6 ligands
11/28/2007CN100351235C 3-z-[1-(4-(n-((4-methyl-piperazin-1-yl)-methylcarbonyl)-n-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate and the use thereof as a pharmaceutical composi
11/28/2007CN100351234C Bis-heterocyclic compounds with antitumour and chemosensitising activity
11/28/2007CN100351233C Fullerene derivative of E-isomer
11/28/2007CN100351232C Anti-obesity agent
11/28/2007CN100351231C Lipid metabolism improving agent
11/28/2007CN100351230C Urea of N-heterocyclic carboxylic acid or the isostere of carboxylic acid and aminocarboxylic acid ester
11/28/2007CN100351225C Symmetrel derivatives and synthesis method thereof and their use as neuron damage protective agent
11/28/2007CN100350978C Medicine-carried degradable type lacrimal duct embolus, and its prepn. method
11/28/2007CN100350977C Medicinal compositions
11/28/2007CN100350975C Anticarcinogen composition
11/28/2007CN100350970C 因子 Factor
11/28/2007CN100350968C Modification of feeding behavior
11/28/2007CN100350941C Bactericidal and disinfecting membrane for birth control
11/28/2007CN100350933C Externally applied medicament for treating mammary gland disease and its preparing method
11/28/2007CN100350926C Medicine for treating acne and its preparing method
11/28/2007CN100350925C Novel snuff aerosol
11/28/2007CN100350924C Product for improving resistance and preventing senile and its manufacturing method
11/28/2007CN100350919C Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
11/28/2007CN100350916C Extraction process of effective component for compound Chinese medicine composition of asiaticoside
11/28/2007CN100350915C Medicine for treating metabolism syndrome
11/28/2007CN100350914C Medicinal composition for antipyretic, analgesic, anti-inflammatory and anti platelet aggregation
11/28/2007CN100350913C Colonic release composition
11/28/2007CN100350912C Nanometer partical administration system of prostaglandin E1 coated with polyglycol derived phospholipid
11/28/2007CN100350911C Pharmaceutical compsn. comprising poorly water-soluble active ingredient, surfactant and water-soluble polymer
11/28/2007CN100350910C Method for preparing freeze dried cefathiamidine
11/28/2007CN100350909C Method for preparing insoluble drug single-tablet-core single-chamber osmotic pump sustained-release preparations and its product
11/28/2007CN100350908C Novel anti-allergic anti-inflammatory composite
11/28/2007CN100350907C Natural antioxidant with human immunity-enhancing and virus-preventing functions
11/28/2007CN100350906C Dichlofenas sodium slow release suppository and its preparation method
11/28/2007CN100350905C Treatment of burns
11/28/2007CN100350904C Coronavirus inactivating agent
11/28/2007CN100350903C Medicaments for treating colics
11/28/2007CN100350902C Hypoglycemic agent, liver protecting agent and anticancer agent containing lignans originating in hongdoushan
11/28/2007CN100350901C Agent for dissolving dental calculi and dental caries
11/27/2007US7302293 Device for transdermal electrotransport delivery of fentanyl and sufentanil
11/27/2007US7301050 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
11/27/2007US7301046 Boronate esters
11/27/2007US7301037 Charged compounds comprising a nucleic acid binding moiety and uses therefor
11/27/2007US7301036 Methyl 4-[(3-methyl-4-methylsufonyl-2-{[4-(trifluoromethoxy)-phenyl]imino}-6-(trifluoromethyl)-2,3-dihydro-1H-benzimidazol-1-yl)methyl]benzoate; glucagon receptor antagonists; type 2 diabetes mellitus
11/27/2007US7301033 3-[3-[N-(Benzoxazol-2-yl)-N-2-(4-chlorophenoxy) ethyl]aminopropoxy]benzoic acid; selectively activate a peroxisome proliferator-activated receptor alpha; hyperlipidemia, arteriosclerosis, diabetes, diabetes complications, inflammation, cardiac diseases
11/27/2007US7301028 Mitotic kinesin inhibitors
11/27/2007US7301024 Crystalline forms of gatifloxacin and processes for preparation
11/27/2007US7301023 Immunosuppressants; grafting of organs; rheumatic diseases
11/27/2007US7301022 N-(2-(6-7-hydroxy-5,6,7,8-tetrahydronaphthalen-1-ylamino)pyrimidin-4-yl)-5-(trifluoromethyl)phenyl)-1-isopropylpyrrolidine-2-carboxamide hydrochloride; antiinflammatory agents, analgesics, antiarthritic agents, antiulcer agents
11/27/2007US7301021 Substituted imidazole compounds
11/27/2007US7301020 identifying macrolide analogs capable of unregulated inhibition of actin filament dynamics; kabiramide C where the 7'-hydroxyl position on the macrolide ring is modified with a methoxycourmarin (MC) or a diethylaminocoumarin (DEAC) group; use of macrolide in fluorescence microscopy of actin filaments
11/27/2007US7300957 Skin care compositions
11/27/2007US7300956 Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
11/27/2007US7300955 Releases nitric oxide and inhibits beta -amyloid formation; such as 4-(nitrooxy)butyl (2)-3-(4-{[3-(4-(2,5-difluorophenyl)-4-{[4-(trifluoromethyl)phenyl]sulfonyl}cyclohexyl)propanoyl]oxy}-3-methoxyphenyl)prop-2-enoate
11/27/2007US7300953 Process for preparing nitrile compound, carboxylic acid compound or carboxylic acid ester compound
11/27/2007US7300952 NF-κb inhibitors
11/27/2007US7300951 Fluoro- and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof
11/27/2007US7300950 Pyrazole derivatives, their preparation and their use in pharmaceuticals
11/27/2007US7300949 For therapy of allergic disorders (e.g., immunodeficiency diseases and hypersensitivity); cardiovascular disorders (e.g., hypertension and arteriosclerosis); dental and oral disorders (e.g., inflammation of the oral mucosa); dermatologic disorders (e.g., dermatitis and skin infections)
11/27/2007US7300948 Useful for the manufacture of a medicament for treating HIV infection in a human infected by HIV. The compounds are potent inhibitors of wild-type (WT) and double mutant strains of HIV-1 RT, particularly the double mutant K103N/Y181C; benzophenone derivatives
11/27/2007US7300947 N-dihydroxyalkyl-substituted 2-oxo-imidazole derivatives
1 ... 3486 3487 3488 3489 3490 3491 3492 3493 3494 3495 3496 3497 3498 3499 3500 3501 3502 3503 3504 3505 3506 ... 7860